WCN26-736 LEYDIG CELL HYPERPLASIA PRESENTING AS PRIMARY AMENORRHEA IN A KIDNEY TRANSPLANT PATIENT WITH FRASIER SYNDROME

Read full text Summarise with VIRAT
Authors: Hygeia Laurei Fernandez, Concesa Casasola, Rafael Rapacon, Allison Kaye Lombridas Pagarigan, Maria Sarah Lenon, Gay Lorraine Cordova, JENINA KATRINA GALVEZ RAYMUNDO, Lisa Angelica Kuhn
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Frasier syndrome is a rare disorder caused by splice-site mutations in the Wilms tumor protein (WT1) gene, characterized by progressive glomerulopathy and gonadal dysgenesis in 46,XY individuals with phenotypic female presentation. It carries an inherent risk for gonadoblastoma and Sertoli cell tumors, while Leydig cell hyperplasia—though associated with shared gonadal developmental pathways—has not been documented in post-kidney transplant patients with this condition. Recognition of atypical gonadal pathology in transplant recipients with primary amenorrhea is vital for timely intervention and optimal endocrine and renal outcomes.

Fields of Study & Subjects

Sexual Differentiation and Disorders Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities Renal and related cancers

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105081–105081
Publication date
25 March 2026
Language
EN